Signal from the log
UltraSight
24 M$ · Series B · Israel · Medtech
UltraSight guide par IA des soignants non spécialistes pour qu'ils réalisent eux-mêmes une échographie du coeur, contre la pénurie d'échographistes cardiaques. Tour qualifié de B2 par la presse.
Spotted
Announced on , logged by the watch of 23 September 2026.
- Operation
- Funding round
- Announced amount
- 24 M$
- Stage
- Series B
- Country
- Israel
- Sector
- Medtech
What the log says
Editorial note, in French
Repérée par la collecte. Personne ne l'a encore instruite.
The investors
Led by Alive HealthTech , with Deep Insight , Star51 Capital , Connecticut Innovations , eHealth Ventures , Mayo Clinic Ventures
Provenance
Source linkedin
Logged on 23 September 2026
Description Written in French during the watch run. Based on the headline as relayed by the source, without reading the issuer's press release.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.